Enanta Pharmaceuticals OverviewEnanta Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for ENTA.
Quarterly Other Income/Expense
-$1.23M
↓ 313.15% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$1.51M
↓ 146.91% YoY
Trailing 12 months ending Mar 31, 2026